A trial of CAM2043

Trial Profile

A trial of CAM2043

Phase of Trial: Phase I

Latest Information Update: 03 Nov 2017

At a glance

  • Drugs Treprostinil (Primary)
  • Indications Pulmonary arterial hypertension
  • Focus Adverse reactions
  • Most Recent Events

    • 03 Nov 2017 New trial record
    • 26 Oct 2017 According to a Camurus media release, this trial is expected to begin in Q4 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top